bioXXmed AG (FRA:T5O)
0.9350
0.00 (0.00%)
Last updated: Oct 28, 2026, 8:00 PM CET
bioXXmed AG Market Cap
bioXXmed AG has a market cap or net worth of €254.19 thousand as of November 18, 2026. It is the 50,815th most valuable company in the world and the 714th biggest in Germany. Its market cap has increased by 31.69% in one year.
Market Cap
254.19K
Enterprise Value
366.19K
Revenue
-269.00
Global Rank
Country Rank
#714 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since December 13, 2006, bioXXmed AG's market cap has decreased from 16.12M to 254.19K, a decrease of -98.42%. That is a compound annual growth rate of -18.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 254.19K | 750.01% |
| Dec 30, 2025 | 29.91K | -95.56% |
| Dec 30, 2024 | 673.01K | -88.20% |
| Dec 30, 2022 | 5.70M | -69.02% |
| Dec 30, 2021 | 18.41M | -70.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.32B |
| Novogenia AG | 75.60M |
| 2invest AG | 37.71M |
| Biomark Diagnostics | 25.98M |
| Vidac Pharma Holding | 11.10M |
| Chosa Oncology AB | 3.35M |
| Paion AG | 328.15K |
| co.don AG | 133.62K |